Production (Stage)
VentriPoint Diagnostics Ltd.
VPTDF
$0.0919
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 92.54% | 277.74% | 37.86% | -5.93% | -30.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 92.54% | 277.74% | 37.86% | -5.93% | -30.25% |
| Cost of Revenue | -- | -100.00% | 4.17% | -27.54% | -36.71% |
| Gross Profit | 123.40% | 481.98% | 42.26% | -1.05% | -29.41% |
| SG&A Expenses | -0.39% | 14.32% | -4.99% | -10.58% | -4.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.04% | 5.06% | -2.10% | -12.09% | -3.65% |
| Operating Income | 3.98% | -3.03% | 2.51% | 12.15% | 3.29% |
| Income Before Tax | -1.21% | -6.61% | 0.29% | 11.38% | 3.70% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.44% | -6.61% | 0.29% | 11.38% | 3.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.44% | -6.61% | 0.29% | 11.38% | 3.70% |
| EBIT | 3.98% | -3.03% | 2.51% | 12.15% | 3.29% |
| EBITDA | 3.91% | -3.12% | 2.42% | 12.07% | 3.21% |
| EPS Basic | 1.30% | -6.25% | 0.42% | 11.51% | 4.17% |
| Normalized Basic EPS | 0.00% | -5.71% | 0.68% | 12.03% | 4.00% |
| EPS Diluted | 1.30% | -6.25% | 0.42% | 11.51% | 4.17% |
| Normalized Diluted EPS | 0.00% | -5.71% | 0.68% | 12.03% | 4.00% |
| Average Basic Shares Outstanding | 0.93% | 0.23% | 0.25% | 0.38% | 0.53% |
| Average Diluted Shares Outstanding | 0.93% | 0.23% | 0.25% | 0.38% | 0.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |